|
---|
Category:CORRESPONDENCE-LETTERS
MONTHYEARML20149D6611993-08-24024 August 1993 Forwards NRC Form 591 Which Indicates One Violation Identified During 930719 Safety Insp of Activities Authorized by License 50-23219-01 IR 05000232/20190011987-06-16016 June 1987 Forwards Amend 2 to License 50-23219-01,per Request.License Changed to Be Consistent W/Encl Current NRC Policy 10CFR35. Leak Testing Requirements Stated in 10CFR35.59.W/o NRC Policy ML20212D9011986-12-18018 December 1986 Requests Listed Addl Info Re 861208 Application for Amend to License 50-23219-01.Number of Hours of Training as Described in Each Group of Encl 1 Should Be Submitted for Each Physician to Be Added to License ML20213F4291986-11-0606 November 1986 Forwards Amend 1 to License 50-23219-01.All Uses of Lixiscope Must Be Conducted in Presence of Holloway or Paton.Ltrs from Administrator of Each Hosp Listed in Condition 10 Should Be Maintained on File ML20213F4411986-09-24024 September 1986 Requests Addl Info Re 860507,0702 & 0828 Applications for Amend to License 50-23219-01,including Training of Holloway on Use of Lixiscope for Diagnostic Studies.Response Requested within 30 Days of Ltr Date ML20213F4521986-07-30030 July 1986 Requests Addl Info Re 860507 & 0702 Applications for Amend to License 50-23219-01,including Outline of Training Program Used by W Paton to Instruct J Holloway in Use of Lixiscope for Diagnostic Studies ML20213F4821986-06-0505 June 1986 Requests Addl Info Re 860507 Application for Amend to License 50-23219-01,including Form NRC-313M Documenting Holloway Training & Experience & Names & Addresses of Facilities Where Lixiscope Will Be Used 1993-08-24
[Table view] Category:DKT 30 MTL BYPRODUCT
MONTHYEARIR 05000232/20190011987-06-16016 June 1987 Forwards Amend 2 to License 50-23219-01,per Request.License Changed to Be Consistent W/Encl Current NRC Policy 10CFR35. Leak Testing Requirements Stated in 10CFR35.59.W/o NRC Policy ML20235X8891987-06-16016 June 1987 Amend 2 to License 50-23219-01 for Alaska Native Medical Ctr,Dept of Health & Human Svcs,Authorizing Listed Individuals to Use &/Or Supervise Use of 500 Mci of Matl Identified in 10CFR35.500 for Medical Use ML20212D9011986-12-18018 December 1986 Requests Listed Addl Info Re 861208 Application for Amend to License 50-23219-01.Number of Hours of Training as Described in Each Group of Encl 1 Should Be Submitted for Each Physician to Be Added to License ML20213F4291986-11-0606 November 1986 Forwards Amend 1 to License 50-23219-01.All Uses of Lixiscope Must Be Conducted in Presence of Holloway or Paton.Ltrs from Administrator of Each Hosp Listed in Condition 10 Should Be Maintained on File ML20213F4241986-11-0606 November 1986 Amend 1 to License 50-23219-01 for Dept of Health & Human Svcs,Alaska Native Medical Ctr,Amending License in Entirety ML20213F4411986-09-24024 September 1986 Requests Addl Info Re 860507,0702 & 0828 Applications for Amend to License 50-23219-01,including Training of Holloway on Use of Lixiscope for Diagnostic Studies.Response Requested within 30 Days of Ltr Date ML20213F4521986-07-30030 July 1986 Requests Addl Info Re 860507 & 0702 Applications for Amend to License 50-23219-01,including Outline of Training Program Used by W Paton to Instruct J Holloway in Use of Lixiscope for Diagnostic Studies ML20213F4821986-06-0505 June 1986 Requests Addl Info Re 860507 Application for Amend to License 50-23219-01,including Form NRC-313M Documenting Holloway Training & Experience & Names & Addresses of Facilities Where Lixiscope Will Be Used ML20135A1211985-08-23023 August 1985 Insp Findings & Licensee Ack on 850823 of License 50-23219-01.Insp Findings:No Violations Observed 1987-06-16
[Table view] Category:OUTGOING CORRESPONDENCE
MONTHYEARML20149D6611993-08-24024 August 1993 Forwards NRC Form 591 Which Indicates One Violation Identified During 930719 Safety Insp of Activities Authorized by License 50-23219-01 IR 05000232/20190011987-06-16016 June 1987 Forwards Amend 2 to License 50-23219-01,per Request.License Changed to Be Consistent W/Encl Current NRC Policy 10CFR35. Leak Testing Requirements Stated in 10CFR35.59.W/o NRC Policy ML20212D9011986-12-18018 December 1986 Requests Listed Addl Info Re 861208 Application for Amend to License 50-23219-01.Number of Hours of Training as Described in Each Group of Encl 1 Should Be Submitted for Each Physician to Be Added to License ML20213F4291986-11-0606 November 1986 Forwards Amend 1 to License 50-23219-01.All Uses of Lixiscope Must Be Conducted in Presence of Holloway or Paton.Ltrs from Administrator of Each Hosp Listed in Condition 10 Should Be Maintained on File ML20213F4411986-09-24024 September 1986 Requests Addl Info Re 860507,0702 & 0828 Applications for Amend to License 50-23219-01,including Training of Holloway on Use of Lixiscope for Diagnostic Studies.Response Requested within 30 Days of Ltr Date ML20213F4521986-07-30030 July 1986 Requests Addl Info Re 860507 & 0702 Applications for Amend to License 50-23219-01,including Outline of Training Program Used by W Paton to Instruct J Holloway in Use of Lixiscope for Diagnostic Studies ML20213F4821986-06-0505 June 1986 Requests Addl Info Re 860507 Application for Amend to License 50-23219-01,including Form NRC-313M Documenting Holloway Training & Experience & Names & Addresses of Facilities Where Lixiscope Will Be Used 1993-08-24
[Table view] |
See also: IR 05000232/2019001
Text
"g . .
_.. $7 % % Q' i $ <
JUL 30 ES6
Docket No. : 030-20377
License No.: 50-23219-01
Control No.: 70396 _
,
Department of Health and Human Services
Alaska Native Medical Center
3rd and Gambell Street
Anchorage, Alaska 99501
Attention: Mr. Frank H. Williams
'
Hospital Environmental Control Coordinator
Gentlemen:
This is in reference to your letters dated May 7, 1986 and July 2, 1986 to
amend your byproduct material license. In order to complete our review, we
need the following additional information:
1. You should submit an outline of the training program used by Dr. William
Paton to instruct Dr. Jordan Holloway in the use of the Lixiscope for
diagnostic studies. Also, indicate the number of hours of training
given for. each topic shown on the outline. This training should be at
least 8 hours9.259259e-5 days <br />0.00222 hours <br />1.322751e-5 weeks <br />3.044e-6 months <br /> in duration and must include Items a. , b. , and d. , as
shown on Form NRC-313M, Supplement A, copy enclosed.
Please note that, as discussed in Appendix A to Regulatory Guide 10.8,
training pertinent to an application should have been obtained within 5
years of the date of the application. Training prior to that time
frame is not normally considered unless the individual has had continuous
involvement in nuclear medicine programs.
>
-
2. Similar training and experience documentation must be submitted for each
physician'to be named on the license as an authorized user.
We will continue the review of your amendment request upon receipt of this
information. If we do not receive a reply from you within 30 calendar days
from the date of this letter, we shall assume that you do not wish to pursue
your application. Please reply in duplicate, and refer to Mail Control No.
70396. .
Sincerely,
8611140213 861106
RECS LIC30
50-23219-01 PDR
R. D. Thomas, Chief
nuclear daterials Saic ty bection
0*C' > .................. ..................... ..................... ..................... ..................... ..................... ..RV..f%...
a'1"'* ~
""~> . M* ;%cmnatw- - - -
out> .................. ..................... ..................... ..................... ..................... .................... .. 7. -./2.7/.8.
. . 6. . .... .
IRC F3.~.M 3tJ ttoisOI NRCM o240 OFFICIAL RECORD COPY W u.s.'oro 29 3-40o.24:
. _ . . . . . ...._..<m.%.- .
. . . . 1... ,- . . . . _ . . . _ . . .. _ _ .. .. _ _ m .. m. .e .me u=-- y
_ _ -